help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on March 27, 2008
Molecular Endocrinology, doi:10.1210/me.2008-0034
Molecular Endocrinology Vol. 0, No. 2008 200800341-
doi:10.1210/me.2008-0034
Copyright © 2008 by the Endocrine Society.
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
22/6/1403    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow NURSA Molecule Pages Link
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhao, L.
Right arrow Articles by Parker, K. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhao, L.
Right arrow Articles by Parker, K. L.

Submitted on January 25, 2008
Accepted on March 20, 2008

CNS-Specific Knockout of Steroidogenic Factor 1 Results in Increased Anxiety-Like Behavior

Liping Zhao, Ki Woo Kim, Yayoi Ikeda, Kimberly K. Anderson, Laurel Beck, Stephanie Chase, Stuart A. Tobet, and Keith L. Parker*

Departments of Internal Medicine and Pharmacology, UT Southwestern Medical Center, Dallas, TX 75390-8857; Department of Histology and Cytology, Yokohama City University School of Medicine, Yokohama, 236-0004, Japan; Department of Biomedical Sciences, Colorado State University, Fort Collins, CO 80523-1617

* To whom correspondence should be addressed. E-mail: keith.parker{at}utsouthwestern.edu.

Steroidogenic factor 1 (SF-1) plays key roles in adrenal and gonadal development, expression of pituitary gonadotropins, and development of the ventromedial hypothalamic nucleus (VMH). If kept alive by adrenal transplants, global knockout (KO) mice lacking SF-1 exhibit delayed-onset obesity and decreased locomotor activity. To define specific roles of SF-1 in the VMH, we used the Cre-loxP system to inactivate SF-1 in a CNS-specific manner. These mice largely recapitulated the VMH structural defect seen in mice lacking SF-1 in all tissues. In multiple behavioral tests, mice with CNS-specific KO of SF-1 had significantly more anxiety-like behavior than wild-type littermates. The CNS-specific SF-1 KO mice had diminished expression or altered distribution in the mediobasal hypothalamus of several genes whose expression has been linked to stress and anxiety-like behavior, including brain-derived neurotrophic factor, the type 2 receptor for corticotropin-releasing hormone (Crhr2), and urocortin 3. Moreover, transfection and electrophoretic mobility shift assays support a direct role of SF-1 in Crhr2 regulation. These findings reveal important roles of SF-1 in the hypothalamic expression of key regulators of anxiety-like behavior, providing a plausible molecular basis for the behavioral effect of CNS-specific KO of this nuclear receptor.

NURSA Molecule Pages Link:

Nuclear Receptors:   SF-1
Ligands:   17β-Estradiol



This article has been cited by other articles:


Home page
Mol. Endocrinol.Home page
K. W. Kim, Y.-H. Jo, L. Zhao, N. R. Stallings, S. C. Chua Jr, and K. L. Parker
Steroidogenic Factor 1 Regulates Expression of the Cannabinoid Receptor 1 in the Ventromedial Hypothalamic Nucleus
Mol. Endocrinol., August 1, 2008; 22(8): 1950 - 1961.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2008 by The Endocrine Society